T1	Participants 51 71	premenopausal women.
T2	Participants 166 171	women
T3	Participants 428 433	women
T4	Participants 530 573	36 premenopausal women, 20 of whom used OC.
T5	Participants 1413 1429	premenopausal OC
T6	Participants 1433 1446	non-OC users.
